Ziprasidone EP Impurity B

Ziprasidone EP Impurity B structurally identified by 5-[2-[4-(1,2-Benzisothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1H-indole-2,3-dione; CAS 1159977-56-6; molecular formula C₂₁H₁₉ClN₄O₂S; molecular weight 426.92 g/mol is a well-characterized pharmaceutical reference standard used in pharmaceutical impurity profiling using Ziprasidone impurity B for detection, separation, and quantification of related substances in drug substances and formulations. It is a recognized forced degradation product of Ziprasidone formed under stability and stress conditions and is important for impurity studies. As a trusted Ziprasidone related compound B analytical standard manufacturer and supplier, Manasa life sciences provide high-purity material suitable for HPLC, LC-MS, GC-MS, and NMR analysis. It is used for analytical method development Ziprasidone impurity B under regulatory guidelines. Supplied with COA, MSDS, chromatographic data, and structural confirmation, this forced degradation product Ziprasidone impurity B is ideal for pharmaceutical R&D, impurity profiling, API development, and quality control. Available for bulk supply and global export with full regulatory support.